Global Gene Therapy for Ovarian Cancer Market Research Report 2023

Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor, and stromal ovarian tumor are some of the less common types. It is the seventh most common cancer in women globally and 18th most common cancer overall. The ovarian cancer immunotherapies market has already got some commercially successful chemotherapy products. However, chemotherapy often involves a combination of two or more drugs, given intravenously every 3-4 weeks, and mostly associated with long-lasting side/adverse effects. Various studies have shown that chemotherapy can damage the blood-producing cells of the bone marrow, resulting in blood-related complications.

The global Gene Therapy for Ovarian Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Gene therapy is expected to be one of the next big paradigm shift in pharmacology due to the extensive on-going research studies, both at academic and industry level. Gene therapy is one of the most exciting approaches for the treatment of ovarian cancer. Replacement gene therapy is gaining attention as it has the potential to cure ovarian cancer and can be used as a promising option for long-lasting treatment.

This report aims to provide a comprehensive presentation of the global market for Gene Therapy for Ovarian Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy for Ovarian Cancer.

The Gene Therapy for Ovarian Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gene Therapy for Ovarian Cancer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapy for Ovarian Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Intravenous

1.2.3 Intratumoral

1.2.4 Intraperitoneal

1.3 Market by Application

1.3.1 Global Gene Therapy for Ovarian Cancer Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Ovarian Cancer (Unspecified)

1.3.3 Recurrent Ovarian Epithelial Cancer

1.3.4 Platinum-Resistant Ovarian Cancer

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Gene Therapy for Ovarian Cancer Market Perspective (2018-2029)

2.2 Gene Therapy for Ovarian Cancer Growth Trends by Region

2.2.1 Global Gene Therapy for Ovarian Cancer Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Gene Therapy for Ovarian Cancer Historic Market Size by Region (2018-2023)

2.2.3 Gene Therapy for Ovarian Cancer Forecasted Market Size by Region (2024-2029)

2.3 Gene Therapy for Ovarian Cancer Market Dynamics

2.3.1 Gene Therapy for Ovarian Cancer Industry Trends

2.3.2 Gene Therapy for Ovarian Cancer Market Drivers

2.3.3 Gene Therapy for Ovarian Cancer Market Challenges

2.3.4 Gene Therapy for Ovarian Cancer Market Restraints

3.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue

3.1.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue (2018-2023)

3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Players (2018-2023)

3.2 Global Gene Therapy for Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gene Therapy for Ovarian Cancer Revenue

3.4 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio

3.4.1 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Ovarian Cancer Revenue in 2022

3.5 Gene Therapy for Ovarian Cancer Key Players Head office and Area Served

3.6 Key Players Gene Therapy for Ovarian Cancer Product Solution and Service

3.7 Date of Enter into Gene Therapy for Ovarian Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Type (2018-2023)

4.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2024-2029)

5.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Application (2018-2023)

5.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2024-2029)

6.1 North America Gene Therapy for Ovarian Cancer Market Size (2018-2029)

6.2 North America Gene Therapy for Ovarian Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023)

6.4 North America Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Gene Therapy for Ovarian Cancer Market Size (2018-2029)

7.2 Europe Gene Therapy for Ovarian Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023)

7.4 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size (2018-2029)

8.2 Asia-Pacific Gene Therapy for Ovarian Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2018-2023)

8.4 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Gene Therapy for Ovarian Cancer Market Size (2018-2029)

9.2 Latin America Gene Therapy for Ovarian Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023)

9.4 Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size (2018-2029)

10.2 Middle East & Africa Gene Therapy for Ovarian Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023)

10.4 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Takara Bio

11.1.1 Takara Bio Company Detail

11.1.2 Takara Bio Business Overview

11.1.3 Takara Bio Gene Therapy for Ovarian Cancer Introduction

11.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023)

11.1.5 Takara Bio Recent Development

11.2 VBL Therapeutics

11.2.1 VBL Therapeutics Company Detail

11.2.2 VBL Therapeutics Business Overview

11.2.3 VBL Therapeutics Gene Therapy for Ovarian Cancer Introduction

11.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023)

11.2.5 VBL Therapeutics Recent Development

11.3 CELSION

11.3.1 CELSION Company Detail

11.3.2 CELSION Business Overview

11.3.3 CELSION Gene Therapy for Ovarian Cancer Introduction

11.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023)

11.3.5 CELSION Recent Development

11.4 Targovax

11.4.1 Targovax Company Detail

11.4.2 Targovax Business Overview

11.4.3 Targovax Gene Therapy for Ovarian Cancer Introduction

11.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023)

11.4.5 Targovax Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Intravenous

    Table 3. Key Players of Intratumoral

    Table 4. Key Players of Intraperitoneal

    Table 5. Global Gene Therapy for Ovarian Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Gene Therapy for Ovarian Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Gene Therapy for Ovarian Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Gene Therapy for Ovarian Cancer Market Share by Region (2018-2023)

    Table 9. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Gene Therapy for Ovarian Cancer Market Share by Region (2024-2029)

    Table 11. Gene Therapy for Ovarian Cancer Market Trends

    Table 12. Gene Therapy for Ovarian Cancer Market Drivers

    Table 13. Gene Therapy for Ovarian Cancer Market Challenges

    Table 14. Gene Therapy for Ovarian Cancer Market Restraints

    Table 15. Global Gene Therapy for Ovarian Cancer Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Gene Therapy for Ovarian Cancer Market Share by Players (2018-2023)

    Table 17. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2022)

    Table 18. Ranking of Global Top Gene Therapy for Ovarian Cancer Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Gene Therapy for Ovarian Cancer Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Gene Therapy for Ovarian Cancer Product Solution and Service

    Table 22. Date of Enter into Gene Therapy for Ovarian Cancer Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Gene Therapy for Ovarian Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2018-2023)

    Table 26. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2024-2029)

    Table 28. Global Gene Therapy for Ovarian Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2018-2023)

    Table 30. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2024-2029)

    Table 32. North America Gene Therapy for Ovarian Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Gene Therapy for Ovarian Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Gene Therapy for Ovarian Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Takara Bio Company Detail

    Table 48. Takara Bio Business Overview

    Table 49. Takara Bio Gene Therapy for Ovarian Cancer Product

    Table 50. Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023) & (US$ Million)

    Table 51. Takara Bio Recent Development

    Table 52. VBL Therapeutics Company Detail

    Table 53. VBL Therapeutics Business Overview

    Table 54. VBL Therapeutics Gene Therapy for Ovarian Cancer Product

    Table 55. VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023) & (US$ Million)

    Table 56. VBL Therapeutics Recent Development

    Table 57. CELSION Company Detail

    Table 58. CELSION Business Overview

    Table 59. CELSION Gene Therapy for Ovarian Cancer Product

    Table 60. CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023) & (US$ Million)

    Table 61. CELSION Recent Development

    Table 62. Targovax Company Detail

    Table 63. Targovax Business Overview

    Table 64. Targovax Gene Therapy for Ovarian Cancer Product

    Table 65. Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2018-2023) & (US$ Million)

    Table 66. Targovax Recent Development

    Table 67. Research Programs/Design for This Report

    Table 68. Key Data Information from Secondary Sources

    Table 69. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Gene Therapy for Ovarian Cancer Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Gene Therapy for Ovarian Cancer Market Share by Type: 2022 VS 2029

    Figure 3. Intravenous Features

    Figure 4. Intratumoral Features

    Figure 5. Intraperitoneal Features

    Figure 6. Global Gene Therapy for Ovarian Cancer Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Gene Therapy for Ovarian Cancer Market Share by Application: 2022 VS 2029

    Figure 8. Ovarian Cancer (Unspecified) Case Studies

    Figure 9. Recurrent Ovarian Epithelial Cancer Case Studies

    Figure 10. Platinum-Resistant Ovarian Cancer Case Studies

    Figure 11. Gene Therapy for Ovarian Cancer Report Years Considered

    Figure 12. Global Gene Therapy for Ovarian Cancer Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Gene Therapy for Ovarian Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Gene Therapy for Ovarian Cancer Market Share by Region: 2022 VS 2029

    Figure 15. Global Gene Therapy for Ovarian Cancer Market Share by Players in 2022

    Figure 16. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy for Ovarian Cancer Revenue in 2022

    Figure 18. North America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Gene Therapy for Ovarian Cancer Market Share by Country (2018-2029)

    Figure 20. United States Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Gene Therapy for Ovarian Cancer Market Share by Country (2018-2029)

    Figure 24. Germany Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Gene Therapy for Ovarian Cancer Market Share by Region (2018-2029)

    Figure 32. China Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Gene Therapy for Ovarian Cancer Market Share by Country (2018-2029)

    Figure 40. Mexico Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Gene Therapy for Ovarian Cancer Market Share by Country (2018-2029)

    Figure 44. Turkey Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Takara Bio Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2018-2023)

    Figure 47. VBL Therapeutics Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2018-2023)

    Figure 48. CELSION Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2018-2023)

    Figure 49. Targovax Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2018-2023)

    Figure 50. Bottom-up and Top-down Approaches for This Report

    Figure 51. Data Triangulation

    Figure 52. Key Executives Interviewed